CUMYL-4CN-BINACA
CUMYL-4CN-BINACA
CUMYL-4CN-BINACA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body. This compound is part of a class of synthetic cannabinoids that are often found in products marketed as "legal highs" or "herbal incense."
Chemical Structure and Properties
CUMYL-4CN-BINACA is chemically classified as an indazole-based synthetic cannabinoid. Its structure includes a cyano group attached to the phenyl ring, which is believed to contribute to its high potency. The compound is designed to mimic the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.
Pharmacology
As a synthetic cannabinoid, CUMYL-4CN-BINACA acts on the CB1 receptor and CB2 receptor, which are G protein-coupled receptors in the central nervous system and peripheral nervous system. The activation of these receptors by CUMYL-4CN-BINACA can lead to a range of effects, including altered perception, mood changes, and impaired motor function.
Legal Status
Due to its potential for abuse and lack of medical use, CUMYL-4CN-BINACA is classified as a controlled substance in many countries. The legal status of synthetic cannabinoids can vary widely, with some jurisdictions implementing specific bans on these compounds.
Health Effects and Risks
The use of CUMYL-4CN-BINACA has been associated with adverse health effects, including tachycardia, hypertension, nausea, and vomiting. In severe cases, it can lead to psychosis, seizures, and even death. The variability in potency and the presence of unknown adulterants in products containing synthetic cannabinoids increase the risk of harmful effects.
Related Compounds
CUMYL-4CN-BINACA is related to other synthetic cannabinoids such as AB-FUBINACA, ADB-PINACA, and 5F-ADB. These compounds share similar mechanisms of action and are often found in similar products.
See Also
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD